745485
Last Update Posted: 2017-02-27
Recruiting has ended
Females accepted | 70 Years + |
186 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid
- The study will assess the safety and tolerability of a single-infusion of zoledronic acid 5 mg administered in a private medical practice setting by a nurse provided by a nationwide infusion service. Safety data will largely be monitored by investigating changes in the patients' well-being during the study.
- The study will pilot and test a Patient Registry and Infusion Service process, which will allow zoledronic acid to be administered to trial patients in the investigators' private rooms by a team of roving nurses.
Eligibility
Relevant conditions:
Osteoporosis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov